EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

BRUSSELS/LONDON (Reuters) -EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of ...

Novo Holdings, Novo Nordisk and Catalent have all recently reiterated ... Reporting by Foo Yun Chee in Brussels and Maggie Fick in London; Editing by Susan Fenton and Sharon Singleton An agenda ...

BRUSSELS/LONDON (Reuters) -EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of contract drug manufacturer Catalent, according to a filing on the European ...

Indiana – while the other two are at Anagni in Italy and Brussels in Belgium. They are set to change hands as soon as the Novo Holdings/Catalent merger is completed, which the companies have ...

Catalent will continue to operate independently and separately from Novo Holdings and Novo Nordisk. The three sites in Anagni, Italy, Brussels in Belgium, and Bloomington, Indiana, in the US will ...